# Doxercalciferol

NDC: 68083-359
Generic name: Doxercalciferol
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190926

FDA application: ANDA210452

## Active ingredients

- DOXERCALCIFEROL: 4 ug/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-359"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-359
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0d79a1b-c7fb-4521-941a-5d6c2fd50170